Juan Francisco D.
- Country
- Spain
- Department
- Cardiology
Research Overview
- Efficacy and Safety of LY3540378 in Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Doxylamine Hydrogen Succinate and Pyridoxine Hydrochloride in Pregnant Women with Nausea and Vomiting: A Multicenter, Open-Label Study
Data & Insights
Has run more than one trial at 0 of 36 partner sites.
Specializations
Heart Failure Management
The investigator specializes in advancing treatments for various forms of heart failure, with particular emphasis on both acute decompensated heart failure and heart failure with preserved ejection fraction (HFpEF).
- Acute Cardiac Care
- Chronic Heart Failure Management
- Cardiac Biomarker Research
Their research encompasses innovative therapeutic approaches in cardiac medicine, focusing on improving clinical outcomes for heart failure patients.
Cardiovascular Therapeutics
The investigator conducts research into novel therapeutic interventions for cardiac conditions, exploring both established and experimental treatment modalities.
- Innovative Drug Applications
- Cardiac Function Assessment
- Treatment Optimization Strategies
Their work includes evaluation of various therapeutic agents for managing different manifestations of heart failure.
Clinical Cardiology
The investigator focuses on understanding and treating atrial myopathy and its relationship to heart failure, particularly in patients with preserved ejection fraction.
- Cardiac Biomarker Analysis
- Heart Function Monitoring
- Disease Progression Assessment
Their expertise extends to evaluating cardiac stability and risk assessment in heart failure patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.